Oxime derivatives of indole and indene compounds as inhibitors o

Details Oxime derivatives of indole and indene compounds as inhibitors o Oxime derivatives of indole and indene compounds as inhibitors o

1996-06-06

1998-05-12

Richter, Johann

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514314, 514365, 514367, 514382, 514561, 546174, 548159, 548181, 548252, 548505, 562428, A61K 3140, C07D20914

Patent

active

057505586

ABSTRACT:
Described herein are compounds having the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein L is selected from the group consisting of ##STR2## R.sup.2 is selected from (a) ##STR3## R.sup.3 is selected from optionally substituted phenyl, and optionally substituted pyridyl; Y is selected from halogen, alkyl, haloalkyl, alkoxy, pyridylmethoxy, thiazolylmethoxy, benzothiazolylmethoxy, quinolylmethoxy, and optionally substituted quinolylmethoxy; W is selected from hydrogen, alkyl, hydroxyalkyl, and hydroxy; A is absent or is selected from optionally substituted alkylene optionally substituted cycloalkylene, optionally substituted cycloalkylene wherein one or two of the carbon atoms is replaced with one or two heteroatoms independently selected from O, S, and N, and ##STR4## and X is absent or is alkylene; Z is selected from (a) hydrogen, (b) COM wherein M is selected from (b-1) a pharmaceutically acceptable metabolically cleavable group, (b-2)--OR.sup.10,(b-3)--O(CH.sub.2).sub.w --CH(OR.sup.12)--CH.sub.2 OR.sup.13, and (b-4)--NR.sup.15 R.sup.16 (c)--OR.sup.17, (d) tetrazolyl, (e)--CH(OR.sup.17)--CH.sub.2 OR.sup.18,(f)--CH(OR.sup.17)--CH.sub.2 --CH.sub.2 OR.sup.18, (g)--CH(OR.sup.17)--CH(OR.sup.18)--CH.sub.2 OR.sup.19, and (h).dbd.N--OR.sup.17 ; and R.sup.1 and R.sup.4 selected from (a) hydrogen, (b) alkyl, and (c) optionally substituted phenyl, are prostaglandin biosynthesis inhibitors and are useful in the treatment of inflammatory disease states. Also disclosed are prostaglandin inhibiting compositions, and a method of inhibiting prostaglandin biosynthesis in a mammal.

REFERENCES:
patent: 2930798 (1960-03-01), Schmitt
patent: 3055912 (1962-09-01), Hoffmann
patent: 5399699 (1995-03-01), Kolasa et al.
J. A. Mitchell et al., "Cyclooxygenase-2: Regulatory and Relevance in Inflamation," Biochemical Pharmacology, vol. 50, No. 10 (1995), 1535-1542.
B. Battistini et al., COX-1 and COX-2: Toward the Development of More Selective NSAIDs Drug News and Perspectives, vol. 7, No. 8 (1994) 501-512.
D. L. DeWitt et al., "The Differential of Prostaglandin Endoperoxide H Synthases-1 and -2 to Nonsteroidal Anti-Inflamatory Drugs: Aspirin Derivatives as Selective Inhibitors," Medicinal Chemistry Research, vol. 5, No. 5, (1995) 325-343.

Affiliated with

Also associated with

Rating

Oxime derivatives of indole and indene compounds as inhibitors o does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxime derivatives of indole and indene compounds as inhibitors o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxime derivatives of indole and indene compounds as inhibitors o will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-979392